Skip to main content
. 2018 Oct 10;12(12):2072–2084. doi: 10.1002/1878-0261.12385

Figure 3.

Figure 3

Kaplan–Meier survival analysis according to the 11‐miRNA classifier stratified by clinicopathological risk factors in the validation cohort. (A, B) TNM stage. (C, D) T stage. (E, F) lymph node status.